Trial Profile
A pivotal trial of LiPlaCis in breast cancer
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 06 Sep 2021
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary)
- Indications Advanced breast cancer
- Focus Registrational; Therapeutic Use
- 02 Jul 2018 According to a Medical Prognosis Institute media release, the Company discussed the proposed design of a pivotal (aimed for marketing approval) randomized trial of LiPlaCis for metastatic breast cancer. DKMA indicated that the planned clinical trial will be considered a pivotal Phase II study if it is accepted for the EMA PRIME program.
- 27 May 2017 New trial record